M.I. Limia Pérez , J.A. Moreno Domingo , L. Juez González , M.J. Fernández Mellado , S. Ajuriagogeaskoa , L. Muñoz Arberas , A. Urones Goikoetxea
{"title":"病例报告:放射性诱导的乳腺脂肪肉瘤","authors":"M.I. Limia Pérez , J.A. Moreno Domingo , L. Juez González , M.J. Fernández Mellado , S. Ajuriagogeaskoa , L. Muñoz Arberas , A. Urones Goikoetxea","doi":"10.1016/j.gine.2024.100998","DOIUrl":null,"url":null,"abstract":"<div><h3>Main symptoms and/or clinical findings</h3><div>Breast sarcoma is a very rare entity that constitutes only 1% of all primary malignant breast tumors. It has a very poor prognosis with a high risk of recurrence. In this article, we present the case of a patient diagnosed with breast liposarcoma after having received radiotherapy for a previous breast carcinoma.</div></div><div><h3>Main diagnoses</h3><div>Due to the rarity of breast liposarcoma, it is important to make an adequate differential diagnosis. In our case, the study of overexpression of the MDM2 and/or CDK4 proteins allowed us to establish the definitive diagnosis.</div></div><div><h3>Therapeutic interventions and results</h3><div>The patient in our case underwent surgery, obtaining tumor-free margins with a favorable subsequent evolution. She currently has 18<!--> <!-->months of disease-free survival.</div></div><div><h3>Conclusion</h3><div>The treatment of breast liposarcoma is mainly surgical since this sarcoma has a poor response to both chemotherapy and radiotherapy. The correct tumor resection is the most important prognostic factor for local control of the disease and long-term survival.</div></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"52 1","pages":"Article 100998"},"PeriodicalIF":0.1000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Descripción de un caso: liposarcoma de mama radioinducido\",\"authors\":\"M.I. Limia Pérez , J.A. Moreno Domingo , L. Juez González , M.J. Fernández Mellado , S. Ajuriagogeaskoa , L. Muñoz Arberas , A. Urones Goikoetxea\",\"doi\":\"10.1016/j.gine.2024.100998\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Main symptoms and/or clinical findings</h3><div>Breast sarcoma is a very rare entity that constitutes only 1% of all primary malignant breast tumors. It has a very poor prognosis with a high risk of recurrence. In this article, we present the case of a patient diagnosed with breast liposarcoma after having received radiotherapy for a previous breast carcinoma.</div></div><div><h3>Main diagnoses</h3><div>Due to the rarity of breast liposarcoma, it is important to make an adequate differential diagnosis. In our case, the study of overexpression of the MDM2 and/or CDK4 proteins allowed us to establish the definitive diagnosis.</div></div><div><h3>Therapeutic interventions and results</h3><div>The patient in our case underwent surgery, obtaining tumor-free margins with a favorable subsequent evolution. She currently has 18<!--> <!-->months of disease-free survival.</div></div><div><h3>Conclusion</h3><div>The treatment of breast liposarcoma is mainly surgical since this sarcoma has a poor response to both chemotherapy and radiotherapy. The correct tumor resection is the most important prognostic factor for local control of the disease and long-term survival.</div></div>\",\"PeriodicalId\":41294,\"journal\":{\"name\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"volume\":\"52 1\",\"pages\":\"Article 100998\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2024-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210573X24000613\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X24000613","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Descripción de un caso: liposarcoma de mama radioinducido
Main symptoms and/or clinical findings
Breast sarcoma is a very rare entity that constitutes only 1% of all primary malignant breast tumors. It has a very poor prognosis with a high risk of recurrence. In this article, we present the case of a patient diagnosed with breast liposarcoma after having received radiotherapy for a previous breast carcinoma.
Main diagnoses
Due to the rarity of breast liposarcoma, it is important to make an adequate differential diagnosis. In our case, the study of overexpression of the MDM2 and/or CDK4 proteins allowed us to establish the definitive diagnosis.
Therapeutic interventions and results
The patient in our case underwent surgery, obtaining tumor-free margins with a favorable subsequent evolution. She currently has 18 months of disease-free survival.
Conclusion
The treatment of breast liposarcoma is mainly surgical since this sarcoma has a poor response to both chemotherapy and radiotherapy. The correct tumor resection is the most important prognostic factor for local control of the disease and long-term survival.
期刊介绍:
Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.